RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
75 hedge funds and large institutions have $355M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 16 closing their positions.
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
2% less capital invested
Capital invested by funds: $364M → $355M (-$8.88M)
7% less funds holding
Funds holding: 81 → 75 (-6)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
57% less call options, than puts
Call options by funds: $17.4M | Put options by funds: $40.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$9.81M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.23M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.87M |
| 4 |
Jane Street
New York
|
+$4.6M |
| 5 |
Millennium Management
New York
|
+$4.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$30.5M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$20.4M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$7.1M |
| 4 |
AC
Armistice Capital
New York
|
-$6.84M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$3.75M |
RPTP Hedge Fund Activity: Q1 2015 in Review
75 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q1 2015, worth a combined $355M — down 2.4% from $364M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of RPTP and 10 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 36 added.
The largest buyer was UBS AM, adding an estimated $9.81M. The largest seller was Royal Bank of Canada, cutting an estimated $30.5M.
- 75 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q1 2015, down from 81 in Q4 2014.
- Funds reported $355M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q1 2015, down 2.4% quarter-over-quarter.
- 10 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q1 2015 and 16 closed out, a net change of -6 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q1 2015 was UBS AM, an estimated $9.81M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q1 2015 was Royal Bank of Canada, an estimated $30.5M sold.
Based on aggregated 13F filings for Q1 2015.